ENTRY       D10177                      Drug
NAME        Trebananib (USAN);
            Trebananib (genetical recombination) (JAN);
            Tovasanib
FORMULA     C2794H4248N752O886S30
EXACT_MASS  63470.2089
MOL_WEIGHT  63510.0817
SEQUENCE    MDKTHTCPPC PAPELLGGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV
            DGVEVHNAKT KPREEQYNST YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA
            KGQPREPQVY TLPPSRDELT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD
            SDGSFFLYSK LTVDKSRWQQ GNVFSCSVMH EALHNHYTQK SLSLSPGKGG GGGAQQEECE
            WDPWTCEHMG SGSATGGSGS TASSGSGSAT HQEECEWDPW TCEHMLE
            (Disulfide bridge: 7-7', 10-10', 42-102, 148-206, 239-246, 275-282, 42'-102', 148'-206', 239'-246', 275'-282')
  TYPE      Peptide
EFFICACY    Antineoplastic, Angiogenesis inhibitor, Angiopoietin antagonist
COMMENT     Trebananib, which inhibits angiopoietin-1 and angiopoietin-2 binding to TIE2 tyrosine kinase receptor.
TARGET      ANGPT1 [HSA:284] [KO:K05465]
            ANGPT2 [HSA:285] [KO:K05466]
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Growth factors (RTK-binding)
                ANGPT1
                 D10177  Trebananib (USAN)
                ANGPT2
                 D10177  Trebananib (USAN)
DBLINKS     CAS: 894356-79-7
            PubChem: 135626895
///
